Comparison of the cognitive effects of three immunomodulatory drugs in relapsing-remitting multiple sclerosis: a longitudinal study.
Phase of Trial: Phase III
Latest Information Update: 22 Sep 2015
At a glance
- Drugs Glatiramer acetate; Interferon beta-1a
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 22 Sep 2015 Last checked against ClinicalTrials.gov record.
- 22 Mar 2012 Actual patient number is 96 according to ClinicalTrials.gov.
- 22 Mar 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.